i think u will find financing less dilutive than expected. Rimas is pretty switched on to shareholders and cum price issue.just opinion mind uamok
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025